Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Oyi-based therapeutic HIV vaccine reduces the HIV RNA rebound median following cART interruption

April 15, 2016

Mymetics' HIV vaccine candidate shows promise in preclinical study

April 12, 2016

Large, multinational studies of anti-HIV antibody VRC-01 launched by NIH

April 8, 2016

FDA approves Gilead's Descovy for the treatment of HIV

April 5, 2016

Bristol-Myers Squibb discloses inhibitors of HIV replication

April 1, 2016

Shionogi patents HIV protease inhibitors

March 31, 2016

Theratechnologies and TaiMed Biologics sign exclusive agreement for ibalizumab

March 22, 2016

Adjunctive sertraline shows efficacy in treatment of HIV-associated cryptococcal meningitis

March 18, 2016

Northwestern University reports development of APOBEC-3G expression enhancers

March 15, 2016

Bristol-Myers Squibb describes HIV integrase inhibitors

March 11, 2016

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...